• Wion
  • /World
  • /Pfizer, BioNTech initial vaccine results impress, but scientists remain cautious - World News

Pfizer, BioNTech initial vaccine results impress, but scientists remain cautious

Pfizer, BioNTech initial vaccine results impress, but scientists remain cautious
Scientists on Monday said initial trial results for Pfizer Inc and BioNTech's coronavirus vaccine far outpaced their expectations for protection against a completely new disease, but that many questions remain unanswered.